edetic acid has been researched along with Minimal Disease, Residual in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arafkas, M; Bania, J; Khosrawipour, T; Khosrawipour, V; Kulas, J; Migdal, P; Pigazzi, A; Schubert, J | 1 |
| Bellò, M; Ceci, F; Cerio, I; Deandreis, D; Dionisi, B; Finessi, M; Nicolotti, DG; Pilati, E; Zotta, M | 1 |
| Afshar-Oromieh, A; Barbato, F; Briganti, A; Calais, J; Cervati, V; Eiber, M; Fanti, S; Farolfi, A; Fendler, WP; Gafita, A; Haberkorn, U; Hadaschik, B; Herrmann, K; Ilhan, H; Pianori, D; Spohn, F; Walz, J; Weber, M; Wetter, A | 1 |
| Cheung, L; Gano, J; Kavanagh, JJ; Kudelka, AP; Murray, JL; Rosenblum, MG; Verschraegen, CF | 1 |
1 trial(s) available for edetic acid and Minimal Disease, Residual
| Article | Year |
|---|---|
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium | 1999 |
3 other study(ies) available for edetic acid and Minimal Disease, Residual
| Article | Year |
|---|---|
Evaluation of Cell-detaching Effect of EDTA in Combination with Oxaliplatin for a Possible Application in HIPEC After Cytoreductive Surgery: A Preliminary in-vitro Study.
Topics: Antineoplastic Agents; Combined Modality Therapy; Cytoreduction Surgical Procedures; Edetic Acid; HT29 Cells; Humans; Hyperthermia, Induced; Neoplasm Recurrence, Local; Neoplasm, Residual; Oxaliplatin; Peritoneal Neoplasms | 2019 |
68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report.
Topics: Aged; Disease Progression; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Humans; Male; Neoplasm, Residual; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence | 2020 |
Topics: Aged; Biomarkers, Tumor; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Oligopeptides; Positron-Emission Tomography; Predictive Value of Tests; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2019 |